[{"source":"Breathing exercises over four to 15 weeks improve functional exercise capacity in people with COPD compared to no intervention; however, there are no consistent effects on dyspnoea or health-related quality of life. Outcomes were similar across all the breathing exercises examined. Treatment effects for patient-reported outcomes may have been overestimated owing to lack of blinding. Breathing exercises may be useful to improve exercise tolerance in selected individuals with COPD who are unable to undertake exercise training; however, these data do not suggest a widespread role for breathing exercises in the comprehensive management of people with COPD.","target":"Output 1: The evidence suggests that diaphragmatic breathing training programs (DBTP) can improve diaphragm participation during natural breathing and increase functional capacity in patients with chronic obstructive pulmonary disease (COPD). However, more studies are needed to determine the optimal frequency, duration, and intensity of DBTP to maximize its benefits. Additionally, other breathing exercises, such as resistive inspiratory muscle training and yoga therapy, have shown promise in improving dyspnea and functional performance in COPD patients. Overall, breathing exercises can be a valuable addition to traditional pulmonary rehabilitation programs for COPD management.\n\nOutput 2: The articles suggest that various breathing exercises, including deep diaphragmatic breathing, oscillatory breathing with flutter VRP1, and exercise with oxygen supplementation, can improve exercise capacity and quality of life in patients with chronic obstructive pulmonary disease (COPD). However, the evidence is not consistently strong across all studies, and some show only modest improvements or no significant effects. More studies are needed to determine the optimal type, duration, and frequency of breathing exercises for COPD patients and to establish their long-term benefits. Overall, the evidence supports the use of breathing exercises as a complementary therapy in COPD management, but further research is required to fully understand their effectiveness and mechanisms of action.\n\nOutput 3: The evidence suggests that breathing exercises, specifically diaphragmatic breathing training programs (DBTP), can improve functional capacity and increase diaphragm participation during natural breathing in patients with chronic obstructive pulmonary disease (COPD). This is supported by several randomized controlled trials. However, more studies are needed to investigate other types of breathing exercises, such as yoga or resistive breathing training, and their long-term effects on COPD patients. Overall, breathing exercises can be a valuable addition to traditional pulmonary rehabilitation programs for COPD patients."},{"source":"The evidence from the limited number of studies suggests that psychological and educational interventions may result in increased abstinence from alcohol, and a reduction in alcohol consumption among pregnant women. However, results were not consistent, and the paucity of studies, the number of total participants, the high risk of bias of some of the studies, and the complexity of interventions limits our ability to determine the type of intervention which would be most effective in increasing abstinence from, or reducing the consumption of, alcohol among pregnant women.","target":"Output 1: The evidence from the provided articles suggests that psychological and educational interventions, such as motivational interviewing, self-help programs, and brief counseling sessions, can effectively reduce prenatal alcohol consumption in pregnant women and women planning pregnancy. The studies report significant reductions in alcohol consumption and quit rates among intervention groups compared to control groups. The strongest effects were observed for light drinkers, African-Americans, and non-Protestants. However, more studies are needed to validate these findings and assess the long-term effectiveness of these interventions. Overall, the evidence is strong enough to support the use of these interventions as a promising approach to reducing prenatal alcohol consumption and improving pregnancy outcomes.\n\nOutput 2: The articles provide evidence for the effectiveness of psychological and educational interventions in reducing prenatal alcohol consumption among pregnant women and those planning pregnancy. The interventions include motivational interviewing, brief counseling, and home visitation programs. The studies show significant reductions in alcohol consumption and improved newborn outcomes, such as higher birthweights and lengths, and lower fetal mortality rates. The evidence is strong enough to support the conclusion that these interventions can be effective in reducing prenatal alcohol exposure. However, more studies are needed to validate the findings and to investigate the long-term effects of these interventions.\n\nOutput 3: The evidence suggests that motivational interventions, such as brief motivational interviews, show promise in reducing prenatal alcohol consumption among pregnant women and those planning pregnancy. These interventions have been shown to result in modest reductions in frequency of alcohol consumption in various populations. However, more studies are needed to validate these findings and to explore the long-term effectiveness of these interventions. The evidence is strong enough to justify the implementation of motivational interventions as a component of prenatal care, but further research is necessary to optimize their impact and reach."},{"source":"The studies included in this review do not allow firm conclusions as to the question of whether the quality of life of people after anterior resection is superior to that of people after abdominoperineal excision\/Hartmann's operation. The included studies challenges the assumption that anterior resection patients fare better.Larger, better designed and executed prospective studies are needed to answer this question.","target":"Output 1: The evidence suggests that patients undergoing rectal resection for cancer, with or without colostomy, experience varying degrees of quality of life (QOL) impacts. Some studies indicate better early QOL with coloanal anastomosis and sphincter preservation, while others report no significant difference in long-term QOL between colostomy and anterior resection groups. However, the evidence is not conclusive, and more studies are needed to validate these findings and determine the optimal treatment strategy for maintaining QOL after rectal resection for cancer.\n\nOutput 2: The evidence suggests that patients undergoing coloanal J-pouch anastomosis report better quality of life than those with abdominoperineal resection or low colorectal anastomosis without a pouch. However, temporary or permanent stoma formation can have significant adverse effects on subsequent health-related quality of life. The longitudinal impact of stoma formation on quality of life in rectal cancer patients undergoing adjuvant chemotherapy shows that stoma patients had similar or significantly improved symptom scores for fatigue, pain, GI problems, and sleep disturbance, but no such improvements were observed in patients without stomas. However, the impairment in social functioning persisted at one and three years after adjuvant chemotherapy. Overall, the evidence is strong enough to support the conclusion that coloanal J-pouch anastomosis leads to better quality of life than abdominoperineal resection or low colorectal anastomosis without a pouch, but the impact of stomas on quality of life should be carefully considered.\n\nOutput 3: The evidence suggests that the quality of life after rectal cancer surgery, with or without a colostomy, is not significantly different from that of the general population. However, patients with stomas may experience impairments in social functioning during adjuvant treatment and persistently thereafter. The choice between treatment options should consider preoperative function and the potential impact on quality of life beyond physical health. While some studies suggest that sphincter preservation may lead to better functional outcomes and quality of life, more research is needed to confirm this. Overall, the evidence is mixed and more studies are needed to provide a definitive conclusion."},{"source":"The information from the single trial in acute postoperative pain suggests it to be a useful analgesic, but at doses not very different from racemic ibuprofen.","target":"Output 1: The provided articles suggest that single doses of dexketoprofen trometamol and ibuprofen are effective in managing moderate to severe postoperative dental pain in adults and adolescents. The evidence is strong enough to conclude that dexibuprofen, as a single dose oral intervention, is an effective option for acute postoperative pain relief in adults based on the significant pain relief and superiority over placebo observed in multiple studies. However, more research may be needed to directly compare dexibuprofen to other NSAIDs, such as dexibuprofen, in larger and more diverse patient populations.\n\nOutput 2: The provided articles suggest that single dose intravenous flurbiprofen and ibuprofen lysine are effective in managing postoperative pain in children and adults, respectively. Etoricoxib, a cyclooxygenase-2 selective inhibitor, also shows promise in providing rapid and effective analgesia in adults. However, more studies are needed to evaluate the efficacy and safety of single dose oral dexibuprofen specifically for acute postoperative pain in adults. The evidence from the provided articles is strong for the use of intravenous flurbiprofen and ibuprofen lysine, but limited for oral dexibuprofen.\n\nOutput 3: Based on the provided articles, there is evidence suggesting that concurrent ibuprofen and paracetamol can provide better analgesic efficacy than either drug alone for acute postoperative dental pain in adults and adolescents. However, there is limited information directly related to the effectiveness of a single dose of oral dexibuprofen for acute postoperative pain in adults. More studies are needed to validate the effectiveness and assess the strength of evidence for this specific intervention."},{"source":"In patients with stable COPD, pMDI produced similar outcomes to a dry powder device for delivering beta2-agonists, but the very small number of studies and included patients does not permit firm conclusions to be drawn. The soft mist device for ipratropium was more effective than a pMDI, but the data come from one small study. There need to be further well designed randomised controlled trials to define the role of inhaler devices using bronchodilators in stable COPD.","target":"Output 1: The articles suggest that metered dose inhalers (MDI), including new devices like Gentlehaler, Clickhaler, and Taifun's MDPI, provide similar bronchodilatory effects to pressurized MDIs when delivering bronchodilators for various respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). The evidence is strong, as multiple randomized controlled trials have shown no significant differences in bronchodilatory response between the investigated devices. However, some studies suggest potential advantages of new devices, such as reduced oropharyngeal deposition, improved patient experience, and cost savings. Overall, the evidence supports the use of various hand-held inhaler devices, including MDIs, as effective alternatives to pressurized MDIs for delivering bronchodilators in chronic obstructive pulmonary disease.\n\nOutput 2: The evidence suggests that metered dose inhalers (MDIs), including pressurized MDIs, are effective in delivering bronchodilators for chronic obstructive pulmonary disease (COPD). However, recent guidelines recommend spacer devices as an easier-to-use and cost-saving alternative. Several studies have shown that MDIs with spacers are equivalent in efficacy to nebulizers and dry powder inhalers. While MDIs have limitations, such as requiring coordination with inhalation, they remain widely used and cost-effective. Overall, the evidence supports the use of MDIs with spacers as a viable option for bronchodilator delivery in COPD patients. However, more studies may be needed to compare the specific effectiveness of pressurized MDIs to other hand-held inhaler devices.\n\nOutput 3: The evidence suggests that metered dose inhalers (MDI), including pressurized MDIs, provide similar bronchodilation to other hand-held inhaler devices, such as breath-actuated systems and dry powder inhalers, in both asthmatics and intubated mechanically ventilated patients. However, MDIs may have higher oropharyngeal deposition, and some studies indicate that low-velocity pressurized MDIs, like Gentlehaler, may reduce oropharyngeal losses and improve patient compliance. Overall, the evidence is strong enough to support the conclusion that MDIs are effective for bronchodilator delivery in chronic obstructive pulmonary disease, but further studies may be needed to compare the specific advantages and disadvantages of different types of MDIs and other hand-held inhaler devices."},{"source":"Providing additional placental blood to the preterm baby by either delaying cord clamping for 30 to 120 seconds, rather than early clamping, seems to be associated with less need for transfusion, better circulatory stability, less intraventricular haemorrhage (all grades) and lower risk for necrotising enterocolitis. However, there were insufficient data for reliable conclusions about the comparative effects on any of the primary outcomes for this review.","target":"Output 1: The evidence from the provided articles suggests that delayed cord clamping in preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis. The studies show that this intervention is feasible and safe, even in very low birth weight infants and at caesarean section deliveries. The benefits include a reduction in the need for packed red cell transfusions during the first 6 weeks of life. However, more studies are needed to assess the clinical relevance of the modest differences between delayed and immediate cord clamping and to validate the conclusions.\n\nOutput 2: The evidence from the provided articles suggests that delayed cord clamping in preterm infants leads to higher haemoglobin levels and improved vascular stability, resulting in less need for packed cell transfusions for anaemia. The studies also indicate that delayed cord clamping may protect preterm infants from intraventricular hemorrhage and late-onset sepsis, especially for male infants. However, more studies are needed to validate these findings and assess the long-term effects on cognitive development and other outcomes. Overall, the evidence is strong enough to suggest that delayed cord clamping is a beneficial intervention for preterm infants, but further research is required to confirm its full impact.\n\nOutput 3: The evidence from the provided articles suggests that delayed cord clamping in preterm infants is associated with a reduced incidence of intraventricular hemorrhage and late-onset sepsis. The feasibility of implementing a delayed cord clamping protocol at various gestational ages and birth methods has also been established. However, more studies are needed to determine the optimal cord clamping delay time and to assess the long-term effects on neurodevelopment and other outcomes. The evidence is strong enough to support the implementation of delayed cord clamping in preterm infants as a standard practice, but further research is necessary to fully understand its benefits and potential risks."},{"source":"This systematic review has not found sufficient evidence to support or refute the effectiveness of HBOT for the management of thermal burns. Evidence from the two randomised controlled trials is insufficient to provide clear guidelines for practice. Further research is needed to better define the role of HBOT in the treatment of thermal burns.","target":"Output 1: Based on the provided articles, the evidence on the use of hyperbaric oxygen therapy for thermal burns is inconclusive. One large clinical trial failed to demonstrate any significant benefit to burn patients from the use of hyperbaric oxygen, while another study suggested that it may be a useful adjunct in the management of foot ulcers in diabetic patients. However, more studies are needed to validate these findings and establish the average effectiveness and optimal use of hyperbaric oxygen therapy for thermal burns.\n\nOutput 2: The evidence suggests that hyperbaric oxygen therapy (HOT) can be an effective adjunct to standard wound care for diabetic foot ulcers and severe trauma of the limbs. For thermal burns specifically, several studies have reported positive effects on wound healing. A randomized controlled trial found that HOT accelerated the healing process and reduced infection rates in burn patients. Another study suggested that HOT may improve functional outcomes and reduce scarring in burn survivors. However, more research is needed to establish the optimal dosage and duration of HOT for burns and to assess its cost-effectiveness. Overall, the evidence is strong enough to support the use of HOT as a valuable adjunct to conventional burn treatments.\n\nOutput 3: The evidence regarding the use of hyperbaric oxygen therapy (HBO) for thermal burns is inconclusive. A large clinical trial involving 125 burn patients failed to demonstrate any significant benefit to patients from HBO, as there were no statistically significant differences in mortality, number of operations, or length of stay between the treatment and control groups. However, some studies suggest that HBO may be beneficial for diabetic foot ulcers and chronic wounds. Overall, more high-quality studies are needed to establish the effectiveness and safety of HBO for thermal burns."},{"source":"Whether ICSI should be preferred to IVF for cases of non-male factor subfertility remains an open question. Further research should report live birth rates and adverse events.","target":"Output 1: The evidence from the provided articles suggests that Intracytoplasmic Sperm Injection (ICSI) may be more effective than conventional insemination techniques for couples with non-male subfertility, as indicated by higher fertilization rates. However, the evidence is not definitive, as some studies did not find significant differences in clinical outcomes between ICSI and conventional techniques. More studies are needed to confirm the superiority of ICSI and to assess its cost-effectiveness and potential complications compared to conventional techniques.\n\nOutput 2: The evidence from the provided articles suggests that conventional in-vitro fertilisation (IVF) is more effective than intracytoplasmic sperm injection (ICSI) in terms of implantation and pregnancy rates in cases of non-male-factor infertility. The studies also indicate that fallopian tube sperm perfusion (FSP) may be more successful than intrauterine insemination (IUI) in the treatment of unexplained infertility. However, the evidence is not conclusive, and more studies are needed to validate these findings. Overall, the evidence supports the current practice of reserving ICSI for severe male-factor problems and using FSP or IUI for unexplained infertility.\n\nOutput 3: The evidence suggests that intracytoplasmic sperm injection (ICSI) is more effective than conventional in-vitro fertilisation (IVF) for oocyte insemination in couples with non-male subfertility, particularly when semen characteristics are poor. However, the difference in fertilization rates is statistically significant only for oocytes treated by conventional IVF. The studies examining the effects of bovine oviductal epithelial cell co-culture and assisted hatching by zona drilling during ICSI cycles showed promising results. Overall, the evidence is strong enough to support the use of ICSI as a more effective intervention for oocyte insemination in couples with non-male subfertility. However, more studies are needed to further validate these findings and explore the potential benefits and risks of ICSI compared to conventional IVF."},{"source":"Medication treatments can be effective in paediatric anxiety disorders, acting to reduce core symptoms, and should be considered as part of the treatment of these disorders. The greatest number of trials showing efficacy to date have assessed the SSRIs in treating paediatric OCD.\nThere is no clear evidence to show that any particular class of medication is more effective or better tolerated than any other. As quantitative data was only available for the SSRIs and venlafaxine the routine use of benzodiazepines cannot be recommended, especially given concerns of dependency and treatment -related emergent adverse events associated with this class of drugs. \n\nFuture RCTs could help identify potential clinical moderators of treatment efficacy. Studies of the long-term efficacy of medication treatment, optimal dosage, as well as direct comparisons of pharmacotherapy and psychotherapy are also warranted.","target":"Output 1: The evidence from the provided articles suggests that selective serotonin reuptake inhibitors (SSRIs) such as sertraline, fluvoxamine, and venlafaxine are effective in treating anxiety disorders in children and adolescents. The studies show significant improvements in anxiety symptoms compared to placebo. However, the combination of pharmacotherapy and cognitive-behavioral therapy (CBT) often yields better results than pharmacotherapy alone. The evidence is strong, but more studies are needed to validate long-term efficacy and safety of these medications in this population.\n\nOutput 2: The evidence from the provided articles suggests that pharmacotherapy, specifically selective serotonin reuptake inhibitors (fluvoxamine) and serotonin-norepinephrine reuptake inhibitors (venlafaxine ER), are effective in reducing symptoms of anxiety disorders in children and adolescents. The studies show significant improvements in anxiety symptoms and functional impairment, with response rates ranging from 54.9% to 80.7%. However, some children did not respond to treatment, and adverse events, including suicidal ideation, were reported. The evidence is strong enough to support the use of pharmacotherapy as an option in the treatment of anxiety disorders in children and adolescents, but more studies are needed to determine the optimal dosage, duration of treatment, and long-term efficacy. Additionally, the combination of pharmacotherapy and cognitive-behavioral therapy may be more effective than monotherapy.\n\nOutput 3: The evidence suggests that selective serotonin reuptake inhibitors (SSRIs) such as fluvoxamine, sertraline, and venlafaxine, and cognitive behavioral therapy (CBT) are effective interventions for anxiety disorders in children and adolescents. Several studies have shown that SSRIs and CBT can reduce anxiety severity and improve functioning. A combination of both therapies may have superior response rates. However, more studies are needed to establish the long-term efficacy and safety of these interventions, particularly in regards to potential adverse events such as treatment-emergent suicidality. Overall, the evidence is strong enough to support the use of SSRIs and CBT as first-line treatments for anxiety disorders in children and adolescents."},{"source":"No clear benefit was shown for open healing over surgical closure. A clear benefit was shown in favour of off-midline rather than midline wound closure. When closure of pilonidal sinuses is the desired surgical option, off-midline closure should be the standard management.","target":"Output 1: Several studies have compared the healing process of pilonidal sinus after surgical excision with primary closure versus secondary intention (open technique). The evidence suggests that primary closure results in faster healing and earlier return to work compared to secondary intention. However, primary closure may have a higher morbidity rate and recurrence rate than secondary intention. The evidence is strong enough to support the conclusion that primary closure leads to faster healing and earlier return to work, but more studies are needed to determine which method has a lower morbidity and recurrence rate. Overall, the choice between primary closure and secondary intention may depend on individual patient preferences and characteristics.\n\nOutput 2: The evidence suggests that primary closure after surgical treatment for pilonidal sinus is more effective than healing by secondary intention in terms of morbidity, recurrence rates, and time before return to work, although healing time is longer (Modified lay-open vs. total excision with primary closure, Primary closure after excision of pilonidal sinus with a transposed rhomboid flap). Hydrocolloid dressings can lessen pain and increase comfort during healing by secondary intention but do not shorten healing time (Effect of hydrocolloid dressings on healing by second intention after excision of pilonidal sinus). Overall, the evidence is strong enough to support the conclusion that primary closure is a more effective healing method after surgical treatment for pilonidal sinus. However, more studies may be needed to validate these findings and to compare the specific techniques and outcomes in more detail.\n\nOutput 3: Several studies have compared primary closure and secondary intention healing after surgical treatment for pilonidal sinus. The evidence suggests that primary closure results in quicker healing time and shorter time off work compared to secondary intention healing. However, primary closure may have a higher recurrence rate, especially in obese patients. Hydrocolloid dressings have been shown to lessen pain and increase comfort for patients during secondary intention healing, but do not shorten healing time. Rhomboid flap transposition and deep suturing techniques for primary closure have similar success rates, but rhomboid flap transposition may result in earlier return to work and no recurrences identified yet. Overall, the evidence supports primary closure as a viable option for pilonidal sinus treatment, but more studies are needed to validate its long-term effectiveness and compare it to other surgical techniques."}]